Toxic Epidermal Necrolyses: Clinical Trials

4 trials for Toxic Epidermal Necrolyses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 completed. 2 Phase 3, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1
Not applicable1Unknown 1
Phase 21Unknown 1

Follow Toxic Epidermal Necrolyses: new trials by email Literature Review of Toxic Epidermal Necrolyses trials Research Report on Toxic Epidermal Necrolyses

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NATIENS: Optimal Management and Mechanisms of SJS/TEN
Harmonized supportive care, Etanercept 50 mg sc day 1 and day 4 - Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses
Phase 3CompletedVanderbilt University Medical Center22023-03-212025-12-17
Severe Bullous Drug Eruption and Filgrastim
Filgrastim, Placebo - Rare Diseases, Toxic Epidermal Necrolyses
Phase 2 / Phase 3UnknownHospices Civils de Lyon422022-05-132024-05-08
Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Maskin Probe - Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses
Not applicableUnknownMassachusetts Eye and Ear Infirmary302021-12-012021-12-06
Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population
A single blood sample for HLA typing - Pemphigus, Bullous Pemphigoid
UnknownSechenov University1202017-05-172022-03-17

Narrower conditions

Stevens-Johnson Syndrome (4)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Dry Eye Syndromes (1)  ·  Meibomian Gland Dysfunction (1)  ·  Meibomitis (1)  ·  Pemphigoid, Bullous (1)  ·  Pemphigus (1)  ·  Rare Diseases (1)

Broader conditions

Chemically-Induced Disorders (4)  ·  Dermatitis (4)  ·  Drug Eruptions (4)  ·  Drug Hypersensitivity (4)  ·  Erythema (4)  ·  Erythema Multiforme (4)  ·  Hypersensitivity (4)  ·  Hypersensitivity, Delayed (4)  ·  Immune System Diseases (4)  ·  Mouth Diseases (4)  ·  Skin Diseases (4)  ·  Skin Diseases, Vesiculobullous (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Stomatitis (4)  ·  Stomatognathic Diseases (4)

Interventions

Etanercept (1)  ·  Filgrastim (1)  ·  Histocompatibility Testing (1)

Sponsors

Hospices Civils de Lyon (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Sechenov University (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (2)  ·  France (1)  ·  Russia (1)

Top investigators

Elizabeth J Phillips, MD (1)